E.coli Test Market

E.coli Test Market by test (Environmental (Membrane Filtration, Multiple Tube Fermentation), Clinical (Polymerase Chain Reaction, Enzyme Immunoassays)) End User (Hospital, Diagnostic Laboratories, Physician Offices) - Global Forecasts to 2023

Report Code: UC 1948 Jan, 2019, by marketsandmarkets.com

The global E.coli test market is expected to reach USD 2.05 billion by 2023 from USD 1.38 billion in 2018, growing at a CAGR of 8.2%. Increasing awareness regarding hygienic, government regulations regarding water and food management, government funding for performing diagnostic tests, non-government organizations (NGO’s) campaigns on water management, increasing prevalence of diarrhoea cases are the major driving factors for this market.

North America dominates the E.coli test market in 2017 and the trend is same during forecast period. Awareness regarding hygienic, stringent government regulations, presence of all key players in the region are the major driving factors for this market in the region. However, Asia Pacific is expected to register robust growth rate during forecast period. This is primarily attributed to improving healthcare infrastructure in the region, government regulation to check the water purity, and focus of major player in the region.

Prominent players in the E.coli test market are Thermo Fisher Scientific (US), Alere Inc (US), Becton, Dickinson and Company (US), BioMerieux Inc. (France), NanoLogix, Inc (US), Meridian Bioscience (US), Bio-Rad Laboratories (US), CPI International, Inc. (US), Pro-Lab Diagnostics, Inc. (Canada), and IDEXX Laboratories, Inc. (US).

Scope of the Report

This research report covers the E.coli test market by Testing Method; end user; and geography.

E.coli Test Market, by Test

  • Environmental Test
    • Membrane Filtration (Mf)
    • Multiple Tube Fermentation (Mtf)
    • Enzyme Substrate Methods
  • Clinical Test
    • Polymerase Chain Reaction (Pcr) Tests
    • Enzyme Immunoassays (Eia)
    • Others

E.coli Test Market, by End User

  • Hospital
  • Diagnostic Laboratories
  • Physician Offices

E.coli Test Market, By Region

  • North America
    • US
    • Canada
  • Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest Of Asia Pacific
  • Rest Of The World (ROW)

Table of Contents

1 Introduction
    1.1 Objective of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered in the Study
    1.4 Stakeholders

2 Research Methodology
    2.1 Market Size Estimation
    2.2 Market Crackdown and Data Triangulation
    2.3 Market Share Estimation
           2.3.1 Key Data Points Taken From Secondary Sources
           2.3.2 Key Data Points Taken From Primary Sources
    2.4 Assumptions

3 Executive Summary

4 Premium Insights

5 Market Overview
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
           5.2.2 Restraints
           5.2.3 Opportunities
           5.2.4 Challenges

6 E.Coli Test Market, By Test
    6.1 Introduction
    6.2 Environmental Test 
           6.2.1 Membrane Filtration (MF)
           6.2.2 Multiple Tube Fermentation (MTF)
           6.2.3 Enzyme Substrate Methods
    6.3 Clinical Test 
           6.3.1 Polymerase Chain Reaction (PCR) Tests
           6.3.2 Enzyme Immunoassays (EIA)
           6.3.3 Others

8 E.Coli Test Market, By End User
    8.1 Introduction
    8.2 Hospital
    8.3 Diagnostic Laboratories
    8.4 Physician Offices
    8.5 Others (If Any)

9 E.Coli Test Market, By Region
    9.1 Introduction
    9.2 North America
           9.2.1 US
           9.2.2 Canada
    9.3 Europe
    9.4 Asia Pacific
           9.4.1 China
           9.4.2 India
           9.4.3 Japan
           9.4.4 Rest of Asia Pacific
    9.5 Rest of the World (RoW)

10 Competitive Landscape
     10.1 Introduction
     10.2 Market Share Analysis
     10.3 Competitive Situation and Trends

11 Company Profiles*
     11.1 Introduction
     11.2 Idexx Laboratories, Inc. 
     11.3 Meridian Bioscience, Inc. 
     11.4 Becton, Dickinson and Company 
     11.5 Thermo Fisher Scientific, Inc. 
     11.6 CPI International, Inc. 
     11.7 Bio-Rad Laboratories, Inc.
     11.8 Pro-Lab Diagnostics, Inc.
     11.9 CPI International, Inc. 
     11.10 CPI International, Inc. 
     11.12 CPI International, Inc. 


Note: *Details on Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured in Case of Unlisted Companies.
* 11 to 15 Market Leaders Will Be Profiled
* Segmentation May Change During the Planned Research Work


Request for detailed methodology, assumptions & how numbers were triangulated.

Please share your problem/objectives in greater details so that our analyst can verify if they can solve your problem(s).
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
UC 1948
Published ON
Jan, 2019
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the E.coli Test Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved